查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954598

全球自體輸血裝置市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034 年）

Autotransfusion Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 141 Pages | 商品交期: 請詢問到貨日

價格

自體輸血裝置市場成長驅動因素

2025 年全球自體輸血裝置市場規模為 3.2961 億美元，預計 2026 年將成長至 3.5097 億美元。到 2034 年，該市場預計將達到 5.9049 億美元，在預測期（2026-2034 年）內，複合年增長率 (CAGR) 為 6.72%。

北美將在 2025 年以 49.76% 的市場佔有率引領全球市場，這主要得益於心血管和骨科手術的增加、完善的醫療基礎設施以及促進術中和術後自體輸血實踐的成熟臨床指南。輸血。

自體輸血（也稱為自體血液回收系統）允許患者在手術期間重新輸注自身血液，從而減少對供血者的依賴。這無需進行交叉配血試驗，最大限度地減少輸血反應，並降低感染風險。這些系統廣泛應用於心血管、骨科、神經外科、婦產科和其他大型外科手術。

市場動態

市場驅動因素

手術數量不斷增加

受心臟病和神經系統疾病等慢性病發病率上升的推動，全球大型外科手術的數量正在增加。術中和術後自體血液回收在血液保存策略中發揮著至關重要的作用。

根據美國關節登記處（2023 年）的數據，美國每年約有 320 萬例髖關節和膝關節置換手術。器官移植手術數量的增加也推動了市場成長。 2023 年，美國共進行了 46,632 例器官移植手術，比 2022 年增加了 8.7%。

此外，老年人口的增長以及慢性疾病的易感性，也推動了術中對先進血液管理系統的需求增長。

市場限制因子

微創手術日益普及

微創手術因其住院時間短、成本低、出血量少等優點而越來越受歡迎。由於這些手術出血量有限，對自體輸血裝置的需求可能會降低。此外，先進止血裝置的研發將進一步減少出血量，這可能會限制自體輸血系統的應用。

市場機會

血液供需缺口

已開發國家和新興國家捐血者短缺日益嚴重，這帶來了巨大的市場機會。在中國，過去十年血液供應量增加了7.0%，而手術量卻增加了18.0%，造成了供需缺口。自體輸血系統為彌合此供需失衡提供了一個可靠的解決方案。

市場挑戰

產品成本高且技術複雜可能會限制其在新興經濟體的應用。此外，在受污染的手術區域感染的風險可能會限制該裝置在某些手術中的使用。

市場趨勢

技術進步

持續的技術創新是關鍵的市場趨勢。 2022年9月，Atlanpol Biotherapeutics的i-SEP自體輸血裝置獲得CE認證，該裝置能夠回收紅血球和血小板。 2023年3月，Hemonetics的下一代智慧控制軟體獲得美國FDA批准，用於CellSaver Elite Plus系統，可提高操作效率和使用者體驗。

市場區隔分析

依產品類型

市場依產品類型分為自體輸血系統及耗材及配件。

到2026年，耗材及配件細分市場將佔主導地位，市場佔有率達58.10%，這主要得益於頻繁的更換需求和手術數量的增加。

由於人們對自體輸血益處的認識不斷提高，包括術中、術後和雙模式系統在內的自體輸血系統預計將穩步增長。自體輸血。

依應用領域劃分

應用領域包括心血管外科、骨科、神經外科和婦科手術。

2024年，心血管外科領域以60.11%的市佔率領先，主要受冠狀動脈繞道手術（CABG）和瓣膜置換術等大出血手術的推動。骨科佔第二大市場佔有率，而神經外科和婦產科預計將溫和成長。

依最終使用者劃分

市場分為醫院和專科診所。

2026年，醫院將佔主導地位，市場佔有率達89.67%，主要受醫院進行的大型手術數量眾多所驅動。由於細胞回收技術的日益普及，專科診所預計將保持穩定成長。

區域概覽

北美

2025年北美市場規模為1.6403億美元，預計2026年將達到1.7485億美元。美國市場預計2026年將達到1.6063億美元。強有力的監管支持和完善的血液管理指南正在推動該地區的成長。

歐洲

由於手術數量的增加和公眾意識的提高，歐洲市場呈現穩定成長態勢。

  • 英國市場：到2026年達到2,170萬美元
  • 德國市場：到2026年達到3,261萬美元

亞太地區

預計亞太地區市場到2034年將維持顯著的複合年增長率。

  • 日本：到2026年達到1224萬美元
  • 中國：到2026年達到1175萬美元
  • 印度：到2026年達到380萬美元

醫療基礎設施的擴建和醫院數量的增加正在推動這一增長。

世界其他地區

巴西、沙烏地阿拉伯和阿拉伯聯合大公國等國的手術數量增加，促進了該地區手術量的穩定成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家心血管手術數量（2025 年）
  • 主要全國骨科手術數量（2025 年）
  • 主要國家婦科手術數量（2025 年）
  • 主要產業趨勢：併購、商業聯盟、新產品與服務介紹
  • 新冠疫情對市場的影響

第五章 全球自體輸血設備市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 自體輸血系統
      • 術中自體輸血系統
      • 術後自體輸血系統
      • 雙模式自體輸血系統
    • 耗材及配件
  • 市場分析、洞察與預測：依應用領域劃分
    • 心臟輸血手術
    • 骨科手術
    • 神經外科手術
    • 婦產科手術
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院
    • 專科診所及其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 世界其他地區

第六章 北美自體輸血裝置市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲自體輸血裝置市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區自體輸血裝置市場分析：洞察與預測（2021-2034）

  • 國家細分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章 世界其他地區（ROW）自體輸血裝置市場分析：洞察與預測（2021-2034）

第10章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Haemonetics Corporation
    • LivaNova PLC
    • Medtronic
    • Fresenius SE &Co. KGaA
    • BD
    • Beijing Jingjing Medical Equipment Co., Ltd.
    • ProCell Surgical Inc.
Product Code: FBI101899

Growth Factors of autotransfusion devices Market

The global autotransfusion devices market was valued at USD 329.61 million in 2025 and is projected to grow to USD 350.97 million in 2026. The market is expected to reach USD 590.49 million by 2034, registering a CAGR of 6.72% during the forecast period (2026-2034).

North America dominated the global market with a 49.76% share in 2025, driven by the increasing number of cardiovascular and orthopedic surgeries, strong healthcare infrastructure, and established clinical guidelines promoting intraoperative and post-operative autotransfusion practices.

Autotransfusion, also known as a cell saver system, allows patients to receive their own blood during surgery, reducing dependence on donor blood. It eliminates cross-matching requirements, minimizes transfusion reactions, and lowers infection risks. These systems are widely used in cardiovascular, orthopedic, neurological, obstetrics & gynecological, and other major surgical procedures.

Market Dynamics

Market Drivers

Rising Number of Surgical Procedures

The growing prevalence of chronic diseases such as cardiac and neurological disorders has increased the number of major surgical procedures globally. Intraoperative and post-operative cell salvage plays a crucial role in blood conservation strategies.

According to the American Joint Replacement Registry (2023), approximately 3.2 million hip and knee arthroplasty procedures were recorded in the U.S. Rising transplant surgeries further support market growth. In 2023, 46,632 organ transplants were performed in the U.S., reflecting an 8.7% increase from 2022.

Additionally, the expanding geriatric population, which is more susceptible to chronic diseases, is increasing demand for advanced blood management systems during surgeries.

Market Restraints

Growing Preference for Minimally Invasive Surgeries

Minimally invasive procedures are gaining popularity due to shorter hospital stays, lower costs, and reduced blood loss. Since these surgeries involve limited bleeding, the need for autotransfusion devices may decline. Moreover, the development of advanced hemostatic devices further reduces blood loss, limiting the adoption of autotransfusion systems.

Market Opportunities

Gap Between Blood Demand and Supply

The increasing shortage of donor blood in both developed and emerging countries presents a significant opportunity. Although blood supply in China grew by 7.0% over the past decade, surgical procedures increased by 18.0%, creating a supply-demand gap. Autotransfusion systems provide a reliable solution to address this imbalance.

Market Challenges

High product costs and technological complexities may limit adoption in emerging economies. Additionally, the risk of infection in contaminated surgical fields may restrict device usage in certain procedures.

Market Trends

Technological Advancements

Continuous innovation is a key market trend. In September 2022, Atlanpole Biotherapies received CE approval for its i-SEP autotransfusion device capable of recovering both red blood cells and platelets.

In March 2023, Haemonetics Corporation received U.S. FDA clearance for next-generation Intelligent Control software for the Cell Saver Elite+ system, enhancing operational efficiency and user experience.

Segmentation Analysis

By Product Type

The market is segmented into autotransfusion systems and consumables & accessories.

The consumables & accessories segment dominated in 2026 with a 58.10% share, driven by frequent replacement needs and increasing surgical volumes.

Autotransfusion systems, including intraoperative, post-operative, and dual-mode systems, are projected to grow steadily due to rising awareness of autologous blood transfusion benefits.

By Application

Applications include cardiovascular, orthopedic, neurological, obstetrics & gynecological surgeries, and others.

The cardiovascular surgeries segment led the market, accounting for 60.11% share in 2024, due to high blood loss procedures such as CABG and valve replacements. Orthopedic surgeries held the second-largest share, while neurological and OB/GYN surgeries are expected to grow at moderate rates.

By End User

The market is divided into hospitals and specialty clinics.

The hospitals segment dominated in 2026 with an 89.67% share, supported by the high volume of major surgeries performed in hospital settings. Specialty clinics are projected to grow steadily with increasing adoption of cell salvage technologies.

Regional Insights

North America

North America accounted for USD 164.03 million in 2025 and is projected to reach USD 174.85 million in 2026. The U.S. market is expected to reach USD 160.63 million in 2026. Strong regulatory support and established blood management guidelines drive regional growth.

Europe

Europe is experiencing steady growth due to rising surgical procedures and increased awareness.

  • UK market: USD 21.7 million by 2026
  • Germany market: USD 32.61 million by 2026

Asia Pacific

Asia Pacific is projected to grow at a significant CAGR through 2034.

  • Japan: USD 12.24 million by 2026
  • China: USD 11.75 million by 2026
  • India: USD 3.8 million by 2026

Expanding healthcare infrastructure and increasing hospital numbers support growth.

Rest of the World

Countries such as Brazil, Saudi Arabia, and the UAE are witnessing rising surgical volumes, contributing to steady regional growth.

Competitive Landscape

The market is highly consolidated, with key players including LivaNova PLC, Haemonetics Corporation, Fresenius SE & Co. KGaA, Medtronic, BD, Beijing Jingjing Medical Equipment Co., and ProCell Surgical Inc.

Companies are focusing on regulatory approvals, partnerships, and product innovation to strengthen their global presence.

Conclusion

The global autotransfusion devices market is set to grow from USD 329.61 million in 2025 to USD 590.49 million by 2034, driven by increasing surgical volumes, rising organ transplants, technological advancements, and the need to address blood supply shortages. North America remains the dominant region, while Asia Pacific presents strong growth opportunities. Despite challenges such as high costs and the rise of minimally invasive surgeries, continued innovation and expanding healthcare infrastructure are expected to sustain steady market expansion through 2034.

Segmentation By Product Type

  • Autotransfusion Systems
    • Intraoperative Autotransfusion Systems
    • Post-operative Autotransfusion Systems
    • Dual-Mode Autotransfusion Systems
  • Consumables & Accessories

By Application

  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics & Gynecological Surgeries
  • Others

By End User

  • Hospitals
  • Specialty Clinics & Others

By Region

  • North America (By Product Type, By Application, By End User, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product Type, By Application, By End User, and By Country/Sub-Region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product Type, By Technology, By End User, and By Country/Sub-Region)
    • Japan (By Application)
    • China (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Rest of the World (By Product Type, By Application, By End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Cardiovascular Surgeries, By Key Countries, 2025
  • 4.2. Number of Major Orthopedic Surgeries, By Key Countries, 2025
  • 4.3. Number of Major Obstetrics & Gynecological Surgeries, By Key Countries, 2025
  • 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships, and Launches
  • 4.5. Impact of COVID-19 on the Market

5. Global Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast- By Product Type
    • 5.1.1. Autotransfusion Systems
      • 5.1.1.1. Intraoperative Autotransfusion Systems
      • 5.1.1.2. Postoperative Autotransfusion Systems
      • 5.1.1.3. Dual-mode Autotransfusion Systems
    • 5.1.2. Consumables & Accessories
  • 5.2. Market Analysis, Insights and Forecast- By Application
    • 5.2.1. Cardiovascular Surgeries
    • 5.2.2. Orthopedic Surgeries
    • 5.2.3. Neurological Surgeries
    • 5.2.4. Obstetrics & Gynecological Surgeries
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast- By End-user
    • 5.3.1. Hospital
    • 5.3.2. Specialty Clinics & Others
  • 5.4. Market Analysis, Insights and Forecast- By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Autotransfusion Systems
      • 6.1.1.1. Intraoperative Autotransfusion Systems
      • 6.1.1.2. Postoperative Autotransfusion Systems
      • 6.1.1.3. Dual-mode Autotransfusion Systems
    • 6.1.2. Consumables & Accessories
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiovascular Surgeries
    • 6.2.2. Orthopedic Surgeries
    • 6.2.3. Neurological Surgeries
    • 6.2.4. Obstetrics & Gynecological Surgeries
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospital
    • 6.3.2. Specialty Clinics & Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Autotransfusion Systems
      • 7.1.1.1. Intraoperative Autotransfusion Systems
      • 7.1.1.2. Postoperative Autotransfusion Systems
      • 7.1.1.3. Dual-mode Autotransfusion Systems
    • 7.1.2. Consumables & Accessories
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiovascular Surgeries
    • 7.2.2. Orthopedic Surgeries
    • 7.2.3. Neurological Surgeries
    • 7.2.4. Obstetrics & Gynecological Surgeries
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospital
    • 7.3.2. Specialty Clinics & Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Autotransfusion Systems
      • 8.1.1.1. Intraoperative Autotransfusion Systems
      • 8.1.1.2. Postoperative Autotransfusion Systems
      • 8.1.1.3. Dual-mode Autotransfusion Systems
    • 8.1.2. Consumables & Accessories
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiovascular Surgeries
    • 8.2.2. Orthopedic Surgeries
    • 8.2.3. Neurological Surgeries
    • 8.2.4. Obstetrics & Gynecological Surgeries
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospital
    • 8.3.2. Specialty Clinics & Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. China
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Rest of the World Autotransfusion Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Autotransfusion Systems
      • 9.1.1.1. Intraoperative Autotransfusion Systems
      • 9.1.1.2. Postoperative Autotransfusion Systems
      • 9.1.1.3. Dual-mode Autotransfusion Systems
    • 9.1.2. Consumables & Accessories
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiovascular Surgeries
    • 9.2.2. Orthopedic Surgeries
    • 9.2.3. Neurological Surgeries
    • 9.2.4. Obstetrics & Gynecological Surgeries
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospital
    • 9.3.2. Specialty Clinics & Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Haemonetics Corporation
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. LivaNova PLC
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Medtronic
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Fresenius SE & Co. KGaA
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. BD
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Beijing Jingjing Medical Equipment Co., Ltd.
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. ProCell Surgical Inc.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 3: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 4: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 5: Global Autotransfusion Devices Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 6: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 7: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 8: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 9: North America Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 10: North America Autotransfusion Devices Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: U.S. Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 12: Canada Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 13: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 15: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 16: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 17: Europe Autotransfusion Devices Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: U.K. Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 19: Germany Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 20: France Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 21: Italy Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 22: Spain Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 23: Scandinavia Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 24: Rest of Europe Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 25: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 27: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 29: Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: China Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 31: India Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 32: Japan Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 33: Australia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Southeast Asia Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 35: Rest of Asia Pacific Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 36: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 37: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Autotransfusion Systems, 2021-2034
  • Table 38: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 39: Rest of the World Autotransfusion Devices Market Revenue (USD million) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Autotransfusion Devices Market Revenue Breakdown (USD million, %) By Region, 2025 & 2034
  • Figure 2: Global Autotransfusion Devices Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 3: Global Autotransfusion Devices Market Value Share (%), By Application, 2025 & 2034
  • Figure 4: Global Autotransfusion Devices Market Value Share (%), By End-user, 2025 & 2034
  • Figure 5: Global Autotransfusion Devices Market Value (USD million), By Region, 2025 & 2034
  • Figure 6: North America Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 7: North America Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 8: North America Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 9: North America Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 10: North America Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 11: North America Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 12: North America Autotransfusion Devices Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Autotransfusion Devices Market Value Share (%), By Country, 2025
  • Figure 14: Europe Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 15: Europe Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 16: Europe Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 17: Europe Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 18: Europe Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 19: Europe Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 20: Europe Autotransfusion Devices Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 21: Europe Autotransfusion Devices Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 22: Asia Pacific Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 24: Asia Pacific Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 27: Asia Pacific Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 28: Asia Pacific Autotransfusion Devices Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Autotransfusion Devices Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Rest of the World Autotransfusion Devices Market Value (USD million), By Product Type, 2025 & 2034
  • Figure 31: Rest of the World Autotransfusion Devices Market Value Share (%), By Product Type, 2025
  • Figure 32: Rest of the World Autotransfusion Devices Market Value (USD million), By Application, 2025 & 2034
  • Figure 33: Rest of the World Autotransfusion Devices Market Value Share (%), By Application, 2025
  • Figure 34: Rest of the World Autotransfusion Devices Market Value (USD million), By End-user, 2025 & 2034
  • Figure 35: Rest of the World Autotransfusion Devices Market Value Share (%), By End-user, 2025
  • Figure 36: Global Autotransfusion Devices Market Share (%), By Company, 2025